M

G

MANCARDI , G

Last name: MANCARDI

First name: G

2021 (v1)

Publication

Metadata-only

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Boffa, G Sbragia, E Raiola, AM

The management of multiple sclerosis patients with persistent disease activity under alemtuzumab treatment is not established yet. Concerns have been raised on the safety of autologous haematopoietic stem cell transplantation (aHSCT) after alemtuzumab treatment because of the risk of serious infectious adverse events. We report short-term...

Uploaded on: April 14, 2023